NCT05081245Phase 2Completed

ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

Study sponsor: MapLight Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-03-10Actual
Enrollment · participants168Actual
Source updated2026-05-19Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 5 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

150 participants (planned)

+ After

168 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Oct 2026

+ After

10 Mar 2026

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source

· 1 field changed

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source